- Home
- SNTG vs AZTR Comparison
SNTG vs AZTR Comparison
Compare SNTG & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- AZTR
- Stock Information
- Founded
- SNTG 2009
- AZTR 2014
- Country
- SNTG China
- AZTR United States
- Employees
- SNTG N/A
- AZTR N/A
- Industry
- SNTG Finance: Consumer Services
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- SNTG Finance
- AZTR Health Care
- Exchange
- SNTG Nasdaq
- AZTR Nasdaq
- Market Cap
- SNTG 5.2M
- AZTR 5.2M
- IPO Year
- SNTG 2021
- AZTR 2023
- Fundamental
- Price
- SNTG $1.68
- AZTR $0.31
- Analyst Decision
- SNTG
- AZTR
- Analyst Count
- SNTG 0
- AZTR 0
- Target Price
- SNTG N/A
- AZTR N/A
- AVG Volume (30 Days)
- SNTG 21.0K
- AZTR 471.2K
- Earning Date
- SNTG 05-06-2025
- AZTR 05-08-2025
- Dividend Yield
- SNTG N/A
- AZTR N/A
- EPS Growth
- SNTG N/A
- AZTR N/A
- EPS
- SNTG N/A
- AZTR N/A
- Revenue
- SNTG $146,472.00
- AZTR $7,500.00
- Revenue This Year
- SNTG N/A
- AZTR N/A
- Revenue Next Year
- SNTG N/A
- AZTR N/A
- P/E Ratio
- SNTG N/A
- AZTR N/A
- Revenue Growth
- SNTG N/A
- AZTR N/A
- 52 Week Low
- SNTG $1.43
- AZTR $0.23
- 52 Week High
- SNTG $3.97
- AZTR $12.00
- Technical
- Relative Strength Index (RSI)
- SNTG 48.37
- AZTR 50.54
- Support Level
- SNTG $1.55
- AZTR $0.27
- Resistance Level
- SNTG $1.77
- AZTR $0.35
- Average True Range (ATR)
- SNTG 0.10
- AZTR 0.03
- MACD
- SNTG 0.01
- AZTR 0.00
- Stochastic Oscillator
- SNTG 73.91
- AZTR 60.00
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.